Smart science to improve lives™

Regulatory news

 

Results, presentations and reports

View our results collateral and archive.

annual report cover

Annual Report

During 2021, the strength and quality of our business model has been further demonstrated.

Analyst consensus

Consensus collated from estimates submitted by side-sell analysts on Croda International Plc.

Genetic research and Biotech science

Acquisitions

Commercialising and increasing our access to new ideas and technologies.

Read more

Excellent first half performance driving profit growth

Excellent first half performance driving profit growth

Read more
Laboratory work

UK Government to support expansion of Croda's lipid systems manufacturing facility

31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.

Read more